Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 496 AL 510

Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials

Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, Fillit H, Hill CV, Hughes L, Irizarry M, Kremen S, Lakdawalla D, Lynn N, Malzbender K, Maruyama T, Massett HA, Patel D, Peneva D, Reiman EM, Romero K, Routledge C, Weiner MW, Weninger S, Aisen PS.

Alzheimers Dement. 2023 Feb;19(2):696-707. doi: 10.1002/alz.12737. Epub 2022 Aug 10.

Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials

Ahmad S, Ahmed SB, Khan A, Wasim M, Tabassum S, Haider S, Ahmed F, Batool Z, Khaliq S, Rafiq H, Tikmani P, Gilani AU.

Metab Brain Dis. 2023 Jan;38(1):17-44. doi: 10.1007/s11011-022-01063-9. Epub 2022 Aug 12.

Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights

Sanaie S, Nikanfar S, Kalekhane ZY, Azizi-Zeinalhajlou A, Sadigh-Eteghad S, Araj-Khodaei M, Ayati MH, Andalib S.

Metab Brain Dis. 2023 Jan;38(1):137-162. doi: 10.1007/s11011-022-01059-5. Epub 2022 Aug 20.

Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics

Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH.

Inflammation. 2023 Feb;46(1):1-17. doi: 10.1007/s10753-022-01721-1. Epub 2022 Aug 20.

Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition

Sharma B, Satija G, Madan A, Garg M, Alam MM, Shaquiquzzaman M, Khanna S, Tiwari P, Parvez S, Iqubal A, Haque SE, Khan MA.

Inflammation. 2023 Feb;46(1):56-87. doi: 10.1007/s10753-022-01730-0. Epub 2022 Aug 25.

Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments

Seyedaghamiri F, Rajabi M, Mohaddes G.

Neurochem Res. 2023 Jan;48(1):26-38. doi: 10.1007/s11064-022-03734-6. Epub 2022 Sep 1.

An insight into the neuroprotective effects and molecular targets of pomegranate (Punica granatum) against Alzheimer's disease

George N, AbuKhader M, Al Balushi K, Al Sabahi B, Khan SA.

Nutr Neurosci. 2023 Oct;26(10):975-996. doi: 10.1080/1028415X.2022.2121092. Epub 2022 Sep 20.

Development of new Alzheimer's disease drug candidates using donepezil as a key model

Eissa KI, Kamel MM, Mohamed LW, Kassab AE.

Arch Pharm (Weinheim). 2023 Jan;356(1):e2200398. doi: 10.1002/ardp.202200398. Epub 2022 Sep 23.

The effects of fenugreek seed extract supplementation in patients with Alzheimer's disease: A randomized, double-blind, placebo-controlled trial

Foroumandi E, Javan R, Moayed L, Fahimi H, Kheirabadi F, Neamatshahi M, Shogofteh F, Zarghi A.

Phytother Res. 2023 Jan;37(1):285-294. doi: 10.1002/ptr.7612. Epub 2022 Oct 5.

An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications

ElHady AK, El-Gamil DS, Abadi AH, Abdel-Halim M, Engel M.

Med Res Rev. 2023 Mar;43(2):343-398. doi: 10.1002/med.21928. Epub 2022 Oct 19.

Lycopene: Sojourn from kitchen to an effective therapy in Alzheimer's disease

Kapoor B, Gulati M, Rani P, Kochhar RS, Atanasov AG, Gupta R, Sharma D, Kapoor D.

Biofactors. 2023 Mar;49(2):208-227. doi: 10.1002/biof.1910. Epub 2022 Nov 1.

The role of transforming growth factor β1 /Smad pathway in Alzheimer's disease inflammation pathology

Yang C, Xu P.

Mol Biol Rep. 2023 Jan;50(1):777-788. doi: 10.1007/s11033-022-07951-8. Epub 2022 Nov 1.

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease

Lane HY, Wang SH, Lin CH.

Psychiatry Clin Neurosci. 2023 Feb;77(2):102-109. doi: 10.1111/pcn.13504. Epub 2022 Nov 24.

Plasmalogens inhibit neuroinflammation and promote cognitive function

Hossain MS, Mawatari S, Fujino T.

Brain Res Bull. 2023 Jan;192:56-61. doi: 10.1016/j.brainresbull.2022.11.005. Epub 2022 Nov 5.

Role of calcium dysregulation in Alzheimer's disease and its therapeutic implications

Joshi M, Joshi S, Khambete M, Degani M.

Chem Biol Drug Des. 2023 Feb;101(2):453-468. doi: 10.1111/cbdd.14175. Epub 2022 Dec 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias